IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 141 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $212,000 | -13.8% | 8,450 | 0.0% | 0.09% | +11.7% |
| Q1 2021 | $246,000 | -34.9% | 8,450 | +3.7% | 0.08% | -52.2% |
| Q4 2020 | $378,000 | +48.8% | 8,150 | 0.0% | 0.16% | +42.5% |
| Q3 2020 | $254,000 | +13.9% | 8,150 | 0.0% | 0.11% | +20.2% |
| Q2 2020 | $223,000 | -8.2% | 8,150 | 0.0% | 0.09% | -13.0% |
| Q1 2020 | $243,000 | +10.0% | 8,150 | 0.0% | 0.11% | +33.3% |
| Q4 2019 | $221,000 | +137.6% | 8,150 | -19.7% | 0.08% | +80.0% |
| Q4 2018 | $93,000 | – | 10,150 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |